Genentech to Invest $750M in Manufacturing Facility in Hillsboro, Oregon

HILLSBORO, ORE. — Genentech, a member of Swiss pharmaceutical company Roche Group, plans to invest $750 million in a new manufacturing facility at its 75-acre campus in Hillsboro. The development will bring new end-to-end device filling capabilities to the site and expand Genentech’s capacity to support its future pipeline of innovative medicines. The new facility will support the manufacturing of advanced drug delivery devices, such as pre-filled syringes and auto injectors. Designed for flexib